Cryo-Cell International, Inc. (NYSE:CCEL)

Tuesday, April 16, 2024 | Web News
Cryo-Cell International Inc (OTC:CCEL) ($7.08; $58.6M market cap) announced Q1 2024 results: Sales of $...
Monday, March 25, 2024 | Web News
Cryo-Cell International Inc (OTC:CCEL) ($6.41; $53.1M market cap) announced plans to explore strategic alternatives and spin-off of its...
Friday, October 13, 2023 | Web News
Cryo-Cell International Inc (OTC:CCEL) ($5.04; $41.7M market cap) a company that provides private and public cord blood banking solutions...
See All Research...
Tuesday, May 11, 2021, 8:09 AM
Perspectives on Cryo-Cell's Position as an Industry Leader in Cord Blood Storage Services [Reasons for Tracking]
See All Articles and Reports...
Sunday, July 21, 2024, 12:28 PM
While Multibagger Turnaround Candidate CAWW And CANOF Performance In Focus, A New Potential Data Center Play Emerges [GeoWire Weekly No. 145]
Sunday, April 21, 2024, 1:17 PM
Finding Fortune In The Fringes: A Perspective On What Microcaps Offer & How To Find That Value [GeoWire Weekly No. 132]
Sunday, March 31, 2024, 4:29 PM
Baseball, Oscar Gamble, And Why You Should Not Ignore Your Bench [GeoWire Weekly No. 129]
See All GeoWire Weekly...
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Web site: http://www.cryo-cell.com

Last updated July 30, 2008


Market Data powered by QuoteMedia. Terms of Use